LU83795A1 - Xanthates,leur preparation et leur utilisation - Google Patents

Xanthates,leur preparation et leur utilisation Download PDF

Info

Publication number
LU83795A1
LU83795A1 LU83795A LU83795A LU83795A1 LU 83795 A1 LU83795 A1 LU 83795A1 LU 83795 A LU83795 A LU 83795A LU 83795 A LU83795 A LU 83795A LU 83795 A1 LU83795 A1 LU 83795A1
Authority
LU
Luxembourg
Prior art keywords
xanthate
alkali metal
group
sodium
potassium
Prior art date
Application number
LU83795A
Other languages
English (en)
French (fr)
Inventor
Arthur Scherm
Klaus Hummel
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of LU83795A1 publication Critical patent/LU83795A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02—Monothiocarbonic acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU83795A 1980-11-26 1981-11-26 Xanthates,leur preparation et leur utilisation LU83795A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3044525 1980-11-26
DE3044525 1980-11-26

Publications (1)

Publication Number Publication Date
LU83795A1 true LU83795A1 (fr) 1983-09-01

Family

ID=6117628

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83795A LU83795A1 (fr) 1980-11-26 1981-11-26 Xanthates,leur preparation et leur utilisation

Country Status (24)

Country Link
US (2) US4602037A (it)
JP (2) JPS5943944B2 (it)
KR (1) KR870001238B1 (it)
AR (1) AR230264A1 (it)
AT (1) AT376202B (it)
AU (1) AU549653B2 (it)
BE (1) BE891245A (it)
CA (1) CA1175047A (it)
CH (1) CH651546A5 (it)
DE (1) DE3146772C2 (it)
DK (1) DK170068B1 (it)
ES (1) ES507430A0 (it)
FR (1) FR2494689B1 (it)
GB (1) GB2091244B (it)
GR (1) GR76308B (it)
HU (1) HU187476B (it)
IE (1) IE51944B1 (it)
IT (1) IT1195297B (it)
LU (1) LU83795A1 (it)
NL (1) NL8105326A (it)
PL (1) PL129383B1 (it)
SE (1) SE450251B (it)
SG (1) SG29285G (it)
YU (1) YU42120B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR870001238B1 (ko) * 1980-11-26 1987-06-26 메르츠+캄패니 게엠베하 앤드 캄패니 크산틴산염의 제조방법
DD286971A5 (de) * 1985-08-02 1991-02-14 Merz U. Co. Gmbh U. Co.,De Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung
DE3625948A1 (de) * 1985-08-02 1987-02-19 Merz & Co Gmbh & Co Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung
IT1213453B (it) * 1985-08-02 1989-12-20 Merz & Co Gmbh & Co Composizione farmaceutica.
US5334395A (en) * 1988-08-04 1994-08-02 Kremers-Urban Company Method of treating an epstein-barr viral infection
US5284664A (en) * 1988-08-04 1994-02-08 Kremers-Urban Company Method of treating the symptoms of Alzheimer's disease
US5316775A (en) * 1988-08-04 1994-05-31 Kremers-Urban Company Method of treating hepatitis B infection
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
EP0450492A1 (en) * 1990-04-06 1991-10-09 Tosoh Corporation Alkylxanthate, production thereof, photopolymerization initiator, and polymerization employing the same
AU4159596A (en) * 1994-11-14 1996-06-06 Ct-Holding Sa Antiviral and antitumor pharmaceutical compositions
DE10117728A1 (de) * 2001-04-09 2002-10-17 Biosphings Ag Pharmazeutische Formulierungen für Xanthogenate
DE10156617A1 (de) * 2001-11-17 2003-05-28 Biosphings Ag Herstellung reiner Stereoisomere von Tricyclo[5.2.1.0··2··.··6··]-dec-9-yl-xanthogenat und Arzneimittel daraus
EP1391221A1 (en) * 2002-08-23 2004-02-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
DE102005031265A1 (de) * 2005-07-05 2007-01-18 Sms Demag Ag Spreizbarer Haspeldorn
DE102006014390A1 (de) 2006-03-29 2007-10-04 Biosphings Ag Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung
CA2691807A1 (en) * 2007-07-03 2009-01-08 Lumavita Ag Stereoisomers of tricyclodecan-9-yl-xanthogenate
SI2315743T1 (sl) * 2008-07-15 2019-08-30 Callery, Llc Postopek čiščenja dialkil sulfidov
US20100221809A1 (en) * 2008-12-23 2010-09-02 The Regents Of The University Of California Compositions and Methods for the Isolation of Biologically Active Proteins
CN114478339B (zh) * 2022-02-14 2023-12-08 中南大学 一种黄原酸盐类捕收剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1854525A (en) * 1929-11-11 1932-04-19 Shell Dev Tertiary xanthates
US1886587A (en) * 1930-01-09 1932-11-08 Hercules Powder Co Ltd Method of preparing xanthates of terpene alcohols
US2037718A (en) * 1932-11-09 1936-04-21 Du Pont Xanthates and method of making same
US2037717A (en) * 1932-11-09 1936-04-21 Du Pont Xanthates and method of making same
FR790353A (fr) * 1934-05-22 1935-11-20 Bataafsche Petroleum Préparation de xanthates
US2161584A (en) * 1936-08-01 1939-06-06 Socony Vacuum Oil Co Inc Petroleum lubricant composition
US2811432A (en) * 1953-07-17 1957-10-29 Monsanto Chemicals Herbicidal composition
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
US3864417A (en) * 1970-01-16 1975-02-04 Chevron Res Saturated hydrocarbon disproportionation at low temperatures
ZA715615B (en) * 1970-10-05 1972-04-26 American Cyanamid Co Manufacture of alkali metal xanthates
US3965137A (en) * 1974-05-02 1976-06-22 Stauffer Chemical Company Thiocyano xanthates
KR870001238B1 (ko) * 1980-11-26 1987-06-26 메르츠+캄패니 게엠베하 앤드 캄패니 크산틴산염의 제조방법

Also Published As

Publication number Publication date
ATA510181A (de) 1984-03-15
IT8125291A0 (it) 1981-11-26
FR2494689A1 (fr) 1982-05-28
KR830007648A (ko) 1983-11-04
NL8105326A (nl) 1982-06-16
AU549653B2 (en) 1986-02-06
DK170068B1 (da) 1995-05-15
ES8400398A1 (es) 1983-11-01
GR76308B (it) 1984-08-04
AR230264A1 (es) 1984-03-01
GB2091244B (en) 1985-02-06
DK522081A (da) 1982-05-27
JPS57118557A (en) 1982-07-23
US4981869A (en) 1991-01-01
HU187476B (en) 1986-01-28
ES507430A0 (es) 1983-11-01
IE51944B1 (en) 1987-04-29
CH651546A5 (de) 1985-09-30
SE450251B (sv) 1987-06-15
DE3146772C2 (de) 1994-09-22
IE812768L (en) 1982-05-26
US4602037A (en) 1986-07-22
KR870001238B1 (ko) 1987-06-26
YU278281A (en) 1984-02-29
GB2091244A (en) 1982-07-28
JPS6328410B2 (it) 1988-06-08
BE891245A (fr) 1982-05-25
SG29285G (en) 1985-11-15
SE8107022L (sv) 1982-05-27
AT376202B (de) 1984-10-25
FR2494689B1 (fr) 1986-07-25
JPS5943944B2 (ja) 1984-10-25
CA1175047A (en) 1984-09-25
JPS591416A (ja) 1984-01-06
DE3146772A1 (de) 1982-09-02
IT1195297B (it) 1988-10-12
YU42120B (en) 1988-04-30
PL129383B1 (en) 1984-05-31
PL233966A1 (it) 1982-07-05
AU7792881A (en) 1982-07-08

Similar Documents

Publication Publication Date Title
LU83795A1 (fr) Xanthates,leur preparation et leur utilisation
EP0015038B1 (fr) Composition pharmaceutique comprenant un dérivé de diphénylhydantoine, dérivés mis en oeuvre et leur préparation
FR2663633A1 (fr) Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2532844A1 (fr) Composition pharmaceutique contenant un compose polyprenylique
EP0087378B1 (fr) Ethers-oximes d'alcoylaminoalcools comme médicaments, produits nouveaux et procédés pour leur préparation
CA1216859A (fr) Procede de preparation de nouveaux derives de l'acide 4-phenyl 4-oxo buten-2-oique
CH661661A5 (fr) Agent antineoplasique.
WO1990006931A1 (fr) Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
FR2481271A1 (fr) Derives de la nonaprenylamine, leurs sels acides d'addition et leur utilisation dans des compositions pharmaceutiques
EP0113330B1 (fr) Composés énamides acylés, compositions pharmaceutiques les contenant, utilisation de ces composés et procédé de préparation de ces composés
EP0037780B1 (fr) Alcoxy propanolamines utiles comme médicaments et procédé pour leur préparation
EP1268470B1 (fr) Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
FR2492821A1 (fr) Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant
CA1174978A (en) Xanthates
KR20020043249A (ko) 염증 치료용 6-메톡시-2-나프틸아세트산 전구약물
EP0022017A1 (fr) Nouveaux dérivés de benzoyl-2 nitro-4 anilides, leur préparation et leur application en tant que médicaments
EP0008269B1 (fr) Nouveaux médicaments contenant, à titre de substance active, des composés de type benzènesulfone, nouveaux composés de ce type et procédé pour leur préparation
EP0482993A1 (fr) Dérivés N,O spirocycliques de cyclotriphosphazènes, leur préparation et leur application en thérapeutique
EP0002638B1 (fr) Sels d'addition d'aralkylamines subsituées et composition thérapeutique les contenant
FR2517672A1 (fr) Thioalcanoyl-carnitines, procede pour leur preparation et composition pharmaceutique les contenant
CH642961A5 (fr) Beta-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leurs procedes de preparation et les compositions pharmaceutiques les renfermant.
FR1450548A (fr) Nouveaux dérivés polyhydroxylés des benzimidazoles
EP0210886B1 (fr) Alcools tertiaires halogéno biphéniles utiles en thérapeutique dans le traitement de l'athérosclérose
EP0039294B1 (fr) Bis (phénoxyacétates substitués) de N-alkyl-dialcanolamines, procédé d'obtention, et compositions pharmaceutiques les contenant
FR2479812A1 (fr) Cycloalcoyl propanol amines utiles comme medicaments et procede pour leur preparation